S.C. Johnson revising Aveeno Bath Treatment oatmeal claims after FDA warning letter.
This article was originally published in The Rose Sheet
Executive Summary
S.C. JOHNSON AVEENO LABELING REVISION: COLLOIDAL OATMEAL ELIMINATED AS ACTIVE ingredient for psoriasis claims made for the company's Aveeno Bath Treatment in Regular and Oilated formulas. S.C. Johnson agreed to the changes in an Aug. 14 letter to FDA's Minneapolis, Minn. district office. In the letter, Racine, Wis.-based S.C. Johnson "questions as to whether or not it is permissible to make claims to `provide prompt temporary relief of itchy, sore sensitive skin due to psoriasis' under the tentative skin protectant monograph" but says it will remove the claim from inner and outer package labeling. S.C. Johnson will also submit a Drug Product Listing amendment to the agency.